Vidhya Murthy
@VidhyaMurthy1
Followers
305
Following
2K
Media
14
Statuses
496
Consultant Haematologist with an interest in myeloid malignancies.
Birmingham, England
Joined March 2020
RT @WilliamAird4: 1/4. SERUM FERRITIN. Regulated at two levels:. ✅ Cytokines (transcriptional control).✅ Iron levels (translational control….
0
99
0
RT @Chethan_Dash: #Space #Update. On a cold, wind-brushed outpost at 14,000 ft in Ladakh, 2 #analogue crew will begin living in isolation t….
0
267
0
RT @isro: GSLV-F16/NISAR. From a majestic liftoff to the flawless separation, witness the full journey. Watch spectacular moments of NISA….
0
1K
0
RT @abouabdrahman0: 🔥 2025 ELN CML MANAGEMENT UPDATE 🔥. 📌 Diagnosis 🧬.•Mandatory detection of BCR::ABL1 via CBA, FISH, RT-PCR. •NGS recomme….
0
31
0
RT @HadjadjJerome: Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed Therapies. https://t.c….
0
2
0
RT @pvyas_oxford: Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome . 10….
ashpublications.org
Key Points. Somatic preleukemic GATA1s mutations are acquired before birth in 25% of neonates with Down syndrome and are not acquired post-natallyRates of
0
3
0
RT @le_markg: It’s finally out in Blood!! .A new molecular scoring system improving ESA response prediction in LR-MDS (ESA-PSS-M). Check i….
ashpublications.org
Key Points. A score including IPSS-M risk score, serum EPO levels and transfusion dependence predicts ESA response in LR-MDS patientsSTAG2 mutations are as
0
5
0
RT @kiranshaw: South India’s longest-know Car-T therapy survivors in Bengaluru return to daily life | Bengaluru News - this is amazing news….
timesofindia.indiatimes.com
Rehan and Parimala, two South Indian cancer survivors, are thriving after Car-T cell therapy at Narayana Health City. Rehan, in remission from lymphom
0
6
0
RT @RabiHannaMD: #regenerative medicine in type 1 DM:.#Stem cell–derived islets (zimislecel) infusion in portal vein restored islet functi….
nejm.org
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...
0
2
0
RT @UsuarezMD: Intermediate-Dose Cytarabine as Postinduction AML Therapy | NEJM Evidence
evidence.nejm.org
We conducted a randomized controlled trial to compare intermediate doses (IDAC) with high doses of cytarabine (HDAC) as postinduction therapy in patients 18 to 60 years of age with newly diagnosed ...
0
15
0
RT @MostafaFaisal14: Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory AML (2013–2022):….
onlinelibrary.wiley.com
Three-year overall survival (OS) and leukaemia-free survival (LFS) rates were 28.5% and 24.4% in allogeneic haematopoietic cell transplantation (HCT) for primary refractory acute myeloid leukaemia...
0
5
0
Disappointing. Subgroup analysis will be key.
0
0
0
Happy 15th Birthday to Queen Elizabeth Hospital @uhbtrust. Fantastic celebrations with Special Kind, Connected and Bold awards. Great to hear aspirations and strategies from the specialties and poster displays of their achievements.
0
0
3
RT @calliecoombsmd: This was an amazing effort and practice changing study for LGL leukemia - cyclophosphamide is superior to MTX with resp….
0
48
0
RT @TalhaBadarMD: #EHA2025 #youngEHA Great presentation by Dr. DiNardo, how to improve on VEN+HMA for intensive ineligible AML pts. 1. Ve….
0
27
0
RT @TalhaBadarMD: Lets start on updates and highlights from #EHA2025 with novel therapies for R/R #AML in development 👇🏽 presented by Norbe….
0
24
0
RT @RCBTweets: 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 ⭐️ RCB PLAYED BOLD! 😇. 17 Years, 6256 Days, 90,08,640 Minutes later, the wait finally ends. 🙌🤯. The IPL Trophy is….
0
31K
0
RT @BrJHaem: First comprehensive analysis of disease causing and rare UBA1 variants in UK populations . https://t.co….
0
6
0